Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (AU:IMR)
ASX:IMR
Want to see AU:IMR full AI Analyst Report?
IMR Stock Chart & Stats
AU$1.64
--
Market closed
AU$1.64
--
Day’s Range― - ―
52-Week RangeAU$1.15 - AU$2.25
Previous CloseN/A
VolumeN/A
Average Volume (3M)287.54K
Market Cap
AU$633.87M
Enterprise ValueAU$361.87M
Total Cash (Recent Filing)AU$40.81M
Total Debt (Recent Filing)AU$26.62M
Price to Earnings (P/E)―
Beta2.00
Next Earnings
Sep 01, 2026Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.06
Shares Outstanding320,947,020
10 Day Avg. Volume240,875
30 Day Avg. Volume287,535
Financial Highlights & Ratios
PEG Ratio0.36
Price to Book (P/B)27.34
Price to Sales (P/S)1042.05
P/FCF Ratio-15.61
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$2.58Price Target Upside57.32% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
EPS Forecast (FY)-0.08
Revenue Forecast (FY)AU$3.52M
Bulls Say, Bears Say
Bulls Say
Niche MRI-guided EP DevicesImricor’s focus on MR-conditional electrophysiology catheters is a durable competitive niche. MRI-guided ablation is a high-barrier, specialized application where device compatibility and procedural integration drive long-term adoption, creating sustainable differentiation if clinical uptake grows.
Recurring Consumables ModelThe per-procedure consumables model supports recurring revenue once clinical adoption is established. Durable cash flow potential arises from repeatable disposables sold each procedure, enabling revenue predictability and margin expansion as installed base and procedure volumes scale over months to years.
Improved Equity PositionRestoring positive equity provides a structural cushion versus prior insolvency risk, improving balance-sheet optics for creditors and investors. This durable improvement lowers near-term solvency pressure and can reduce the urgency and dilution risk of emergency capital raises if operational trends stabilize.
Bears Say
Collapse In RevenueA dramatic and persistent drop in revenue undermines the company’s path to scale. Durable recovery requires sustained clinical adoption and sales execution; absent that, fixed costs and R&D spending will continue to outpace sales, limiting operating leverage and strategic optionality over the medium term.
Negative Gross Profit & Large LossesConsistently negative gross margins and outsized net losses indicate structural issues with unit economics or extremely low volume. Without meaningful margin improvement or scale, the business cannot self-fund growth, exacerbating dilution or financing needs and threatening long-term viability.
Heavy Cash Burn & Elevated LeverageSustained negative operating cash flow and substantial debt create refinancing and dilution risk. High cash burn depletes runway absent new funding, while elevated leverage amplifies interest and covenant risk, constraining strategic investments and heightening long-term financial stress if revenue recovery lags.
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh News
IMR FAQ
What was Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh’s price range in the past 12 months?
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh lowest share price was AU$1.15 and its highest was AU$2.25 in the past 12 months.
What is Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh’s market cap?
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh’s market cap is AU$633.87M.
When is Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh’s upcoming earnings report date?
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh’s upcoming earnings report date is Sep 01, 2026 which is in 120 days.
How were Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh’s earnings last quarter?
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh released its earnings results on Feb 24, 2026. The company reported AU$0 earnings per share for the quarter, beating the consensus estimate of -AU$0.032 by AU$0.032.
Is Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh overvalued?
According to Wall Street analysts Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh’s price is currently Undervalued.
Does Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh pay dividends?
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh does not currently pay dividends.
What is Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh’s EPS estimate?
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh’s EPS estimate is 0.
How many shares outstanding does Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh have?
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh has 320,947,020 shares outstanding.
What happened to Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh’s price movement after its last earnings report?
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh reported an EPS of AU$0 in its last earnings report, beating expectations of -AU$0.032. Following the earnings report the stock price went up 1.508%.
Which hedge fund is a major shareholder of Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh?
Currently, no hedge funds are holding shares in AU:IMR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
AU$2.58 (57.32% Upside)
AU$2.58 (57.32% Upside)
Blogger Sentiment
Bullish
AU:IMR Sentiment 100%
Sector Average 72%
Sector Average 72%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
102.70%
12-Months-Change
Fundamentals
Return on Equity
-109.63%
Trailing 12-Months
Asset Growth
96.47%
Trailing 12-Months
Company Description
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh
Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States. The company's principal products include the Advantage-MR EP Recorder/Stimulator system, an EP recording system and integrated cardiac stimulator; Vision-MR Ablation Catheter, which is used as an indication for treating type I atrial flutter; and Vision-MR Dispersive Electrode that is used to minimize eddy currents induced on the conductive pads during MR scanning. It also performs contract research, as well as licenses its intellectual property for use in implantable devices. Imricor Medical Systems, Inc. was incorporated in 2006 and is headquartered in Burnsville, Minnesota.
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (IMR) Earnings & Revenues
IMR Stock 12 Month Forecast
Average Price Target
AU$2.58
▲(57.32% Upside)
Technical Analysis
Impedimed Limited
―
HeraMED Ltd.
―
Cyclopharm Limited
―
Micro-X Ltd.
―
EMvision Medical Devices Ltd.
―
Options Prices
Currently, No data available
---